Skip to main content

Enzo Biochem Inc

ENZBDelisted Apr 7, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000316253

Enzo Biochem Inc was delisted on Apr 7, 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.

13F holders, Q3 2024

Institutional positions in Enzo Biochem Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
43
+5 vs. Q2 2024
Shares held
12.6M
+1.22M (+10.7%) vs. Q2 2024
Total value
$14.2M
+$1.72M (+13.8%) vs. Q2 2024
New holders
7
7 more added
Sold out
2
6 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ENZB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 43 institutions
Q1 2021: 82 institutionsQ2 2021: 72 institutionsQ3 2021: 65 institutionsQ4 2021: 59 institutionsQ1 2022: 51 institutionsQ2 2022: 54 institutionsQ3 2022: 49 institutionsQ4 2022: 52 institutionsQ1 2023: 52 institutionsQ2 2023: 47 institutionsQ3 2023: 39 institutionsQ4 2023: 46 institutionsQ1 2024: 41 institutionsQ2 2024: 39 institutionsQ3 2024: 43 institutionsQ4 2024: 44 institutionsQ1 2025: 41 institutionsQ2 2025: 7 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2024: $14.2M
Q1 2021: $94.6MQ2 2021: $76.6MQ3 2021: $82.9MQ4 2021: $69.0MQ1 2022: $62.0MQ2 2022: $43.8MQ3 2022: $45.6MQ4 2022: $26.8MQ1 2023: $48.1MQ2 2023: $34.7MQ3 2023: $23.1MQ4 2023: $22.7MQ1 2024: $17.6MQ2 2024: $13.5MQ3 2024: $14.2MQ4 2024: $9.71MQ1 2025: $4.96MQ2 2025: $2.00MQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ENZB and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20257$2.00M
Q1 202541$4.96M
Q4 202444$9.71M
Q3 202443$14.2M
Q2 202439$13.5M
Q1 202441$17.6M
Q4 202346$22.7M
Q3 202339$23.1M
Q2 202347$34.7M
Q1 202352$48.1M
Q4 202252$26.8M
Q3 202249$45.6M
Q2 202254$43.8M
Q1 202251$62.0M
Q4 202159$69.0M
Q3 202165$82.9M
Q2 202172$76.6M
Q1 202182$94.6M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Enzo Biochem Inc; share changes are against Q2 2024.

Institutions holding ENZB in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Harbert Fund Advisors, Inc.5,175,913$5.80M4.67%00.0%Unchanged
Renaissance Technologies LLC2,527,529$2.83M0.00%+27,983+1.1%Added
Vanguard Group Inc1,876,622$2.10M0.00%00.0%Unchanged
BlackRock, Inc.959,151$1.07M0.00%+959,151New
Geode Capital Management, LLC368,646$413.0K0.00%+11,742+3.3%Added
Dimensional Fund Advisors LP304,492$341.1K0.00%−35,841−10.5%Reduced
RBF Capital, LLC250,359$280.4K0.01%00.0%Unchanged
Bridgeway Capital Management, LLC180,800$202.5K0.00%+48,700+36.9%Added
State Street Corp154,139$172.6K0.00%00.0%Unchanged
Wittenberg Investment Management, Inc.117,137$131.2K0.04%00.0%Unchanged
BBR Partners, LLC100,000$112.0K0.01%+100,000New
Nierenberg Investment Management Company, Inc.88,555$99.2K0.06%00.0%Unchanged
Morgan Stanley71,855$80.5K0.00%+100+0.1%Added
Northern Trust Corp67,204$75.3K0.00%00.0%Unchanged
Squarepoint Ops LLC56,646$63.4K0.00%+56,646New
Lazard Asset Management LLC50,453$56.0K0.00%00.0%Unchanged
Price T Rowe Associates Inc44,800$51.0K0.00%00.0%Unchanged
XTX Topco Ltd34,354$38.5K0.00%+6,092+21.6%Added
Citadel Advisors LLC26,594$29.8K0.00%+26,594New
Kempner Capital Management Inc.25,475$29.0K0.01%00.0%Unchanged
Millennium Management LLC25,745$28.8K0.00%+6,382+33.0%Added
Paradigm Financial Partners, LLC19,500$22.2K0.00%+19,500New
FNY Investment Advisers, LLC20,000$22.0K0.01%+20,000New
Raymond James Trust N.A.17,016$19.1K0.00%00.0%Unchanged
Shulman DeMeo Asset Management LLC15,487$17.3K0.00%00.0%Unchanged
Manufacturers Life Insurance Company, The14,955$16.8K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc13,471$15.1K0.00%00.0%Unchanged
TLS Advisors LLC13,616$15.0K0.03%00.0%Unchanged
Snowden Capital Advisors LLC10,245$11.5K0.00%−1,800−14.9%Reduced
Covestor Ltd3,967$4.00K0.00%00.0%Unchanged
BFSG, LLC2,813$3.15K0.00%00.0%Unchanged
Simplex Trading, LLC2,765$3.00K0.00%+1,164+72.7%Added
Tower Research Capital LLC (TRC)2,414$2.70K0.00%−1,849−43.4%Reduced
Bank of America Corp2,213$2.48K0.00%−10.0%Reduced
JPMorgan Chase & Co1,833$2.05K0.00%00.0%Unchanged
Royal Bank of Canada1,000$1.00K0.00%−81−7.5%Reduced
Wells Fargo & Company578$6480.00%00.0%Unchanged
FMR LLC429$4800.00%00.0%Unchanged
UBS Group AG278$3110.00%−445−61.5%Reduced
Advisor Group Holdings, Inc.120$1340.00%00.0%Unchanged
Clear Point Advisors Inc.120$1340.00%00.0%Unchanged
BNP Paribas79$880.00%+79New
Sound Income Strategies, LLC10$110.00%00.0%Unchanged
Assenagon Asset Management S.A.0$00.00%−19,773−100.0%Sold out
Benjamin Edwards Inc0$00.00%−300−100.0%Sold out
BlackRock Inc.––––Not filed